Eric Fallon, PhD
Genentech Inc
Senior Director, Head of Global Biologics Manufacturing Sciences and Technology
Eric Fallon is responsible for Global Biologics Manufacturing Sciences and Technology (MSAT), Drug Substance at Roche/Genentech. He leads a Global MSAT team that is responsible for providing ongoing technical support of Roche’s commercial biologics drug substance (DS) manufacturing across the internal and external manufacturing network. Eric also chairs the Roche Biologics Drug Substance Technical Council, which is tasked with aligning the global Roche DS Network (internal and external) on implementation of globally impacting new technologies and improvement of current bioprocess technologies.
Prior to his current role, Eric was responsible for the Technology function at Genentech’s Oceanside Product Operations, which comprised leadership of process technology transfers into the Oceanside site, providing technical support for ongoing biologics drug substance manufacturing, and coordination of process and technology improvement efforts in collaboration with the Genentech/Roche Pharma Technical Operations network. Eric previously led the Oceanside Manufacturing Sciences group upon Genentech’s acquisition of the Oceanside manufacturing facility in 2005, and prior to that managed the Cell Culture Manufacturing Sciences group within BioPharmaceutical Development at Biogen Idec, Inc. He began his career at Idec Pharmaceuticals within Cell Culture Process Development. Eric received his Ph.D. degree in Chemical Engineering from the Massachusetts Institute of Technology. Eric has an M.S. in Chemical Engineering Practice from M.I.T., and a B.S. in Chemical Engineering from the University of California-Berkeley.
Prior to his current role, Eric was responsible for the Technology function at Genentech’s Oceanside Product Operations, which comprised leadership of process technology transfers into the Oceanside site, providing technical support for ongoing biologics drug substance manufacturing, and coordination of process and technology improvement efforts in collaboration with the Genentech/Roche Pharma Technical Operations network. Eric previously led the Oceanside Manufacturing Sciences group upon Genentech’s acquisition of the Oceanside manufacturing facility in 2005, and prior to that managed the Cell Culture Manufacturing Sciences group within BioPharmaceutical Development at Biogen Idec, Inc. He began his career at Idec Pharmaceuticals within Cell Culture Process Development. Eric received his Ph.D. degree in Chemical Engineering from the Massachusetts Institute of Technology. Eric has an M.S. in Chemical Engineering Practice from M.I.T., and a B.S. in Chemical Engineering from the University of California-Berkeley.